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Background: A significant number of individuals suffer from plantar heel pain (PHP) and many go on to have
chronic symptoms and continued disability. Persistence of symptoms adds to the economic burden of PHP and
cost-effective solutions are needed. Currently, there is a wide variation in treatment, cost, and outcomes of care for
PHP with limited information on the cost-effectiveness and comparisons of common treatment approaches. Two
practice guidelines and recent evidence of effective physical therapy intervention are available to direct treatment
but the timing and influence of physical therapy intervention in the multidisciplinary management of PHP is unclear.
The purpose of this investigation is to compare the outcomes and costs associated with early physical therapy
intervention (ePT) following initial presentation to podiatry versus usual podiatric care (uPOD) in individuals with
PHP.
Methods: A parallel-group, block-randomized clinical trial will compare ePT and uPOD. Both groups will be seen
initially by a podiatrist before allocation to a group that will receive physical therapy intervention consisting primarily of
manual therapy, exercise, and modalities, or podiatric care consisting primarily of a stretching handout, medication,
injections, and orthotics. Treatment in each group will be directed by practice guidelines and a procedural manual,
yet the specific intervention for each participant will be selected by the treating provider. Between-group differences in
the Foot and Ankle Ability Measure 6 months following the initial visit will be the primary outcome collected by an
independent investigator. In addition, differences in the European Quality of Life – Five Dimensions, Numeric
Pain Rating Scale, Global Rating of Change (GROC), health-related costs, and cost-effectiveness at 6 weeks,
6 months, and 1 year will be compared between groups. The association between successful outcomes based
on GROC score and participant expectations of recovery generally, and specific to physical therapy and podiatry
treatment, will also be analyzed.
Discussion: This study will be the first pragmatic trial to investigate the clinical outcomes and cost-effectiveness of
ePT and uPOD in individuals with PHP. The results will serve to inform clinical practice decisions and management
guidelines of multiple disciplines.
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Plantar heel pain (PHP), or plantar fasciitis, is a common
condition that approximately 1–2 million Americans re-
ceive treatment for each year [1,2]. Individuals with PHP
commonly have prolonged and recurrent symptoms that
cost from $192 to $396 million to treat annually [3-7].
Actual healthcare costs for PHP management are likely
higher because this estimate reflects only 818,000 of the
1–2 million individuals estimated to have PHP annually
and does not include indirect costs, such as loss of work
productivity or costs associated with treatment provided
by podiatrists and physical therapists [2].
The etiology of PHP is multifactorial including inflam-
mation, chronic tendinopathy, foot posture or mobility
dysfunction, lower leg inflexibility, mobility impairments of
the foot, ankle, knee and hip, and neurodynamic dysfunc-
tion [8-17]. Due to the multifactorial nature of PHP, many
terms such as plantar fasciitis, plantar fasciopathy, and
plantar fasciosis have been used to describe the condition.
Furthermore, there are a number of different treatments
proposed to be effective in PHP and multiple healthcare
providers that offer primary care for PHP [18-20].
Providers within the healthcare system that manage
PHP include podiatrists, physical therapists, chiroprac-
tors, primary care physicians, and orthopedic surgeons.
Prevalence estimates for individuals with PHP that seek
care from non-physician providers who manage PHP is
not available. However, approximately 1 million visits for
PHP were made each year to office or hospital-based
physicians between the years 1995 and 2000 [2]; 62% of
visits were made to primary care physicians and 31% to
orthopedic surgeons, with physical therapy ordered or
provided at 19% of these visits [2]. In addition to physi-
cians, there is evidence to suggest that individuals with
PHP also visit podiatrists and physical therapists fre-
quently as primary providers for this problem. It has
been estimated that up to 15% of patients seeking care
from a podiatrist have a chief complaint of PHP and a
survey of podiatrists indicated that PHP was the most
prevalent condition in podiatry practice [21,22]. A sur-
vey of physical therapists in orthopedic practice indi-
cated that PHP was the most common foot condition
seen [23]. While physicians, podiatrists, and physical
therapists each see a significant number of individuals
with PHP, the primary role of several different disci-
plines may contribute to the observed variance in
PHP management [2].
Clinical guidelines can provide direction in the pres-
ence of practice variation and multiple treatment op-
tions. Currently there are two clinical guidelines on PHP
provided by the American College of Foot and Ankle
Surgeons (ACFAS) and the Orthopaedic Section of the
American Physical Therapy Association (APTA) [19,20].
Both guidelines are intended for use by podiatry andphysician specialties, although the APTA guidelines are
also intended for use by physical therapists [24]. While
there are many common recommendations between the
two guidelines, including foot and lower leg stretching,
taping, orthotics, and night splints, there is an apparent
difference in recommendations for the timing of referral
to a physical therapist and inclusion of common physical
therapy interventions for PHP. ACFAS guidelines rec-
ommend 6 weeks of unresponsive treatment and testing
to include imaging (e.g., radiographs), corticosteroid in-
jections, orthotics, taping, oral anti-inflammatories, and
an unsupervised home program before referral to a
physical therapist. In contrast, APTA guidelines do not
indicate a timeline for certain interventions as described
in the ACFAS guidelines. Additionally, recommenda-
tions for iontophoresis, manual therapy, and supervised
exercise are included in the APTA guidelines without
specific mention in the ACFAS guidelines. Since the APTA
guidelines were written in 2008, additional evidence has
been published supporting the use of manual therapy inter-
ventions in the management of PHP [10,25,26]. The
conflicting recommendations of the ACFAS and APTA
guidelines may result in different healthcare utilization
patterns. Following the ACFAS recommendations, there is
likely to be greater utilization of corticosteroid injections,
oral medication, and radiographs in the first 6 weeks
whereas a greater utilization of manual therapy and exer-
cise procedures may result from following the APTA
guidelines and recent manual therapy evidence. The
discrepancies between guidelines and discipline-specific
practice patterns for PHP contribute to uncertainty in the
best management strategy of primary providers for PHP.
An important factor to clarify is the role of physical ther-
apy intervention within the first 6 weeks that a patient
presents to a provider for PHP.
Early physical therapy intervention versus a delayed
referral has demonstrated improved outcomes, de-
creased likelihood of surgery and injections, fewer office
visits, and reduced advanced imaging and medication in
individuals with low back pain [27-29]. No investigations
were found on the impact of early physical therapy inter-
vention in PHP. If physical therapy intervention provided
early after initial presentation to a provider for PHP can
reduce utilization of healthcare while improving out-
comes, this would be a significant contribution to the eco-
nomic and disability-related burden of PHP. Therefore,
the purpose of this investigation is to compare the out-
comes and costs associated with usual podiatric care
(uPOD) versus early physical therapy intervention (ePT)
in patients with PHP.
Specific aims
Aim 1: Compare the difference in outcome between ePT
versus uPOD. The null hypothesis that no difference in
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ePT and uPOD in individuals with PHP at the 6-month
follow-up will be tested using a randomized clinical trial.
Aim 2: Compare the difference in secondary outcome
measures using the 3-item (average, worst, least) nu-
meric pain rating scale (NPRS), and global rating of
change (GROC) scale. These measures will be taken
concurrently with the FAAM in the randomized clinical
trial to test the null hypothesis that there is no difference
in NPRS and GROC between ePT and uPOD.
Aim 3: Compare the cost-effectiveness of ePT versus
uPOD. Costs and quality of life measures will be cap-
tured concurrently in the randomized clinical trial to
calculate incremental cost-effectiveness ratios and test
the null hypothesis that there is no difference in cost-
effectiveness between ePT and uPOD.
Aims 1 and 2 will be the focus of this paper although
Aim 3 will also be considered in the planning of this
project and is included here for clarity of the entire pro-
ject’s scope. The procedures to accomplish Aim 3 will be
outlined in a subsequent publication.Methods
Study design
This investigation will be a block randomized clinical
trial comparing participant-reported outcomes and cost-
effectiveness of ePT and uPOD with follow-up extending
to 1 year (Figure 1).Figure 1 Diagram of participant flow through the study. BMI:
Body mass index; DMU: Des Moines University; ePT: Early physical
therapy intervention; EQ-5DTM: European Quality of Life – Five
Dimensions; FAAM: Foot and Ankle Ability Measure; GROC: Global
rating of change; NPRS: Numeric pain rating scale; PI: Principle
investigator; uPOD: Usual podiatric care.Setting and ethical approval
The location for this study will be the Podiatry and
Physical Therapy Departments at the Des Moines Uni-
versity Clinic, Des Moines, IA, USA. This study has re-
ceived Institutional Review Board (IRB) Approval from
Des Moines University (IRB identification, 04-13-02)
and Rocky Mountain University of Health Professions
(IRB identification 131034–02). Within the Des Moines
University IRB approval, agreements regarding review of
protected health information in preparation for research,
and extraction of data from electronic health records
were made between the Des Moines University Clinic
and the principle investigator. As a part of this agreement,
all enrolled participants will sign a Health Insurance Port-
ability and Accountability Act of 1996 authorization to
use and disclose individual health information for research
purposes form in addition to the informed consent form.
Participants
Individuals presenting with a primary complaint of PHP
to the Podiatry Department of the Des Moines Univer-
sity Clinic will be recruited for this study. Participants
will be included if they have a primary clinical diagnosis
of PHP determined by having tenderness to palpation of
the plantar aspect of the heel and pain associated with
first step after waking in the morning or with progression
of weight-bearing during the day. Eligible participants will
be between the ages of 18–60 and demonstrate a score of
less than 74/84 on the FAAM activities of daily living
(ADL) subscale to allow for improvement of at least the
minimum clinically important difference [30]. Participants
will be excluded if they had prior surgery of the foot,
ankle, or lower leg; clinical signs of radiculopathy; contra-
indications to manual therapy interventions (i.e., tumor,
fracture, rheumatic inflammatory disease [rheumatoid, re-
active and psoriatic arthritis, inflammatory bowel disease,
ankylosing spondylitis, and systemic lupus erythematosus],
osteoporosis, prolonged history of steroid use, severe vas-
cular disease, etc.); clinical indication of plantar fascia rup-
ture; are unable to complete questionnaires; unable or
unwilling to comply with treatment recommendations of
either treatment group; or had prior treatment for PHP in
the past 6 weeks. In addition, individuals who have a body
mass index (BMI) greater than 30 kg/m2 or symptoms for
longer than 1 year will be excluded due to the greater risk
of chronic symptoms and poor response to conservative
management [4,6,13,31].
The number of participants for this study is based on
the power needed to detect between-group differences
in the primary outcome measure, the FAAM, at
6 months. In the absence of research comparing physical
therapy and podiatry interventions or podiatry interven-
tions using the FAAM as an outcome measure, sample
size calculations are based on achieving a clinically








Prior history of PHP (yes/no)
Duration of symptoms (days)
Foot Posture Index [38]




Healthcare resource use (US dollars)*
General recovery expectation†






*Data derived from a participant-reported questionnaire. †Measured by rating
expected recovery according to the GROC scale [34]. ‡As measured on a 0–10
visual analog scale where 0 = not helpful and 10 = extremely helpful relative to
plantar heel pain. BMI: Body mass index; ePT: Early physical therapy intervention;
EQ-5D™: European Quality of Life-Five Dimensions; FAAM: Foot and Ankle Ability
Measure; NPRS: Numeric pain rating scale; PHP: Plantar heel pain; uPOD: Usual
podiatric care.
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from a recent clinical trial by Cleland et al. [10] that
used similar methods to this investigation. Sample size
estimate was made using G*Power 3.1.5 based on de-
tecting a difference between groups greater than the
minimal clinically important difference (MCID) (i.e., 9
point change) of the FAAM at 6 months with an alpha
level of 0.05, 80% power, and pooled sample variance
of 14.5 from Cleland et al. [10,30,32]. This resulted in
an effect size of 0.62 and 42 participants needed per
group. To account for participants who drop-in or
drop-out of treatment, in addition to the possibility of
some participants not returning the FAAM question-
naire, the sample will be increased by 33% resulting in
56 participants per group. The focus, and consequently
the power analysis of this investigation is on functional
outcome (based on FAAM scores) and therefore may
result in underpowered analysis of secondary variables.
Outcome measures
Outcomes will be collected at 6 weeks, 6 months, and
1 year after initial presentation. An investigator blinded
to group allocation will collect all primary and secondary
outcome measures. A small financial incentive will be
provided to facilitate completion of outcome measures
over the study duration.
Primary outcome measure
The FAAM ADL subscale will be used to assess participant-
reported functional outcome. The FAAM has demonstrated
an intraclass correlation coefficient of 0.89 and a MCID of 8
for the ADL subscale [30].
Secondary outcome measures
A 3-item, 0–10 (0 = no pain, 10 = worst imaginable pain),
NPRS will be used to assess average pain in addition the
lowest and highest levels of pain in the past week. The
average of the three ratings will be used to represent
overall pain intensity. The 3-item NPRS has demon-
strated test-retest reliability of 0.61, and an MCID of 2
points [33]. The GROC scale will be used to assess
participant-reported improvement. The GROC is a sin-
gle question item that includes 15 ranks for global im-
provement from −7 (a very great deal worse) to 0 (about
the same) to +7 (a very great deal better) [34]. Scores
of +5 have previously been used as an indicator of clin-
ical success [10,35]. Overall health status will be mea-
sured by the European Quality of Life-Five Dimensions
(EQ-5D™). The EQ-5D™ is a general measure of health-
related quality of life that includes five items related to
mobility, self-care, usual activities, pain/discomfort,
and anxiety/depression [36]. Index scores from the
United States general population will be applied to theEQ-5D™ to calculate the quality-adjusted life year,
where 0.0 = death and 1.0 = perfect health [37].
Intervention
All patients will attend one visit with a podiatrist where
the podiatrist will perform an evaluation and provide
intervention based upon usual practice patterns. After
this visit, the patient will be invited to participate in the
study and undergo a baseline examination that will collect
data on variables indicated by Table 1. A member of the
office staff will randomize group assignment using ran-
dom block sizes of 4 and 6, and concealed envelopes con-
taining group assignment to ePT or uPOD (Figure 1).
Early physical therapy intervention group (ePT)
Individuals in the ePT will be managed by a physical
therapist in accordance with the APTA plantar heel
pain practice guidelines and recent evidence in support
of manual therapy intervention [10,19,25,26]. Treat-
ment provided will be based on identified impairments
and may include manual therapy (joint and soft tissue
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the body), lower leg and plantar foot specific stretching/
self-mobilization, foot and lower leg muscle performance
training, night splints, taping, over-the-counter orthotics/
heel cup/heel cushion, and iontophoresis. The specific
intervention will be selected at the discretion of the
treating physical therapist, yet will be guided by a man-
ual of procedures that directs intervention priorities
and progression based on current best evidence (Tables 2
and 3). The principle investigator will conduct training
sessions with each ePT provider to assure comprehension
of the items and interventions included in the manual
of procedures. Training sessions are estimated to last
1–4 hours per provider and will be conducted in brief
sessions with follow-up until each therapist reports
comprehension. Participants in the ePT group will be
managed by the physical therapist without additional
podiatric intervention until the participant achieves a
GROC of “quite a bit better” and demonstrates inde-
pendence in condition management strategies or a
plateau in progress demonstrated by GROC or FAAM
scores. While participants in the ePT group will be
managed primarily by the physical therapist, they are
free to return to the podiatrist if they choose.
Usual podiatric care group (uPOD)
Individuals in the uPOD group will receive care typical
of podiatric management of PHP at the Des Moines
University Clinic that is in accordance with the recently
updated practice guideline [20]. According to the guide-




Exercise Stretching/mobility: Plantar fascia-specific, ankle dorsiflex
(knee bent and straight), self-lateral heel glide [10,19]
Manual therapy Impairment based treatment directed at the ankle and
foot [10,25,26]
Modalities Iontophoresis with dexamethasone in cases with highly
irritable and acute symptoms [19]
Tape/Orthotics If participants do not present with an orthotic and did n
receive one from their podiatry visit, the Treatment Dire
Test [52] will be used for short-term pain relief and ortho
consideration.
Night splint If symptoms persist for >6 months and this has not bee
tried previously [19]
Education Preliminary information about plantar heel pain includin
prognosis, home program, and modifiable contributing
factors (e.g., footwear, body weight, flexibility, foot
loading/weight-bearing)
Home program Home program will include less than 5 of Tier 1 or
2 exercises to facilitate adherence [55]taping/padding, home stretching exercises, over-the-
counter arch support/heel cup, shoe recommendations,
oral anti-inflammatories, and corticosteroid injections.
If the participant is non-responsive to the first 6 weeks
of treatment, the guideline indicates the next 6 months
of treatment should include corticosteroid injections,
custom orthotics, a night splint, immobilization, and
referral to a physical therapist [20]. If the participant is
not responsive after 6 months of treatment, extracor-
poreal shock wave therapy or a fasciotomy surgery is
recommended per the guideline [20]. Extracorporeal
shock wave therapy is not available at Des Moines Uni-
versity and partial or full fasciotomy is performed in
less than 1% of patients. In addition to the treatment
indicated above, the podiatrist may order radiographs
or ultrasound imaging within their scope of practice. The
specific intervention will be selected at the discretion of
the treating podiatrist and Figure 2 indicates the preva-
lence of intervention and testing procedures from a ran-
dom sample of care episodes between February 2008 and
August 2011 at the Des Moines University Podiatry Clinic.
Statistical analysis
Baseline group variables will be summarized using the
mean and standard deviation for continuous measures
and percentages for categorical measures. Independent
t-tests (P <0.05, two-tailed) or the appropriate nonpara-
metric test will be used to compare between-group dif-
ferences in baseline characteristics (Table 1). Parametric
test assumptions will be analyzed for all continuous vari-
ables by visual inspection of histograms, use of skewnessthe early physical therapy intervention group
Second tier interventions
ion Stretching/mobility of the posterior thigh [39-41], and
identified impairments of areas proximal to the lower leg
Muscle performance training of foot and lower leg
[12,42-47], in addition to identified impairments of proximal
regions [48,49]
Impairment based treatment directed at regions proximal to







g Brief pain neuroscience if central sensitization or peripheral
neuropathic pain mechanisms are identified [53,54]
Table 3 Phases and progression of physical therapy treatment
Phase Goals Criteria for advancement to next phase Interventions
Phase I 1. Decrease irritability 1. Mild to moderate pain 1. Address contributing factors (footwear,
orthotics, taping, neurodynamic
impairments)2. Educate participant on condition
and rehabilitation
2. Dorsiflexion ≥10 degrees (measured in prone with knee
extended) [11], or symmetrical dorsiflexion to uninvolved
side 2. Participant education
3. Improve dorsiflexion 3. Modalities
4. Stretching/self-mobilization
a. Home Program; <5 exercises [55]
b. Night splint (if symptoms persist
for >6 months) [19]
5. Manual therapy
Phase II 1. Further reduction in pain 1. Minimal to no pain 1. Exercise*
2. Single leg heel raise ≥12 repetitions [56], or symmetrical
performance to the uninvolved side
2. Manual therapy*
2. Restore muscle performance 3. Gait training
3. Minimize gait deviations 3. Walking items on FAAM≤ “slight difficulty”
4. Enhance basic function(s)
Phase III 1. Enhance higher level function(s)
including sport and recreational
activities
Discharge when: 1. Progression of exercise
GROC≥ “quite a bit better” and participant demonstrates
understanding of independent condition management
2. Sport/recreation specific training




Plateau evident in GROC or FAAM scores and participant
demonstrates understanding of independent condition
management
*Manual therapy during Phase II will address residual impairments from Phase I but Phase II treatment will reflect greater volume of exercise interventions than
manual therapy compared to Phase I. FAAM: Foot and Ankle Ability Measure; GROC: Global rating of change scale.
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teria, and Levene’s test for homogeneity of the variance.
A repeated measures analysis of variance will be used
to compare group differences in the FAAM, NPRS,
EQ-5D™, and number of office visits associated with treat-
ment at each time point. Results will be reported as theFigure 2 Usual podiatric care (uPOD) represented by the
percentage of patients and time relative to initial presentation
of podiatric intervention or testing by podiatrists at the study
location. MRI: Magnetic resonance imaging; OTC: Over-the-counter.group mean, mean difference between groups, 95% confi-
dence intervals, f-value, P value, power, and effect size. The
χ2 test will be used to compare GROC scores between
groups at each time point and results will be reported as
the χ2 value, P value, and the frequency per category.
The types of treatment based on Current Procedural
Terminology and Healthcare Common Procedure Coding
System codes provided per group will be reported as
percentages. Analysis of covariance will be used if any
group differences are observed in participant characteris-
tics. Intention-to-treat analysis will be performed by com-
paring the complete case analysis to multiple imputation
analysis. Multiple imputed data sets will be generated
using the Multivariate Imputation by Chained Equations
algorithm with SPSS 19.0 for Windows (SPSS Inc.,
Chicago, IL, USA). Multinomial logistic regression will be
used to obtain pooled regression estimates from the data
sets that will be used for analysis. Post-randomization
exclusion of included participants that did not meet
eligibility criteria or that did not receive intervention
will be considered for exclusion of the analysis by an
independent, blinded adjudication committee that will
evaluate all randomized participants [57]. Any cross-
overs will be analyzed in the original group to which
they were assigned. A separate analysis excluding
crossovers will be performed.
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uPOD will be categorized into three categories; matched,
unmatched, and neutral. Participants will be labelled
‘matched’ if they are allocated to a group for which they
have expressed a higher expectation of benefit. A higher ex-
pectation will be denoted by comparison of visual analog rat-
ings between the groups (ePT and uPOD; Additional file 1).
Unmatched participants will be those who are allocated to
the treatment group for which they have a lower expectation
of benefit. Neutral participants will be those who indicate
the same level of expectation for both treatments. Similar
categorizations will be made for participant preference based
upon their response to the treatment preference question
(Additional file 1). General expectations of improvement will
be dichotomized into met or unmet based upon rankings at
the 6-week, 6-month, and 1-year follow-up relative to
baseline rankings. Participants that demonstrate 6-week,
6-month, and 1-year ranks equal to or higher than base-
line will be considered to have met their global expecta-
tions of improvement. Participants that demonstrate
rankings below baseline expectations will be considered to
have unmet global expectations of improvement. A χ2 test
of independence will be used to compare the proportions
of individuals with matched/unmatched/neutral expecta-
tions or preferences to global expectations (met or un-
met). In addition, differences in expectation and preference
categories will be analyzed relative to treatment success
using a χ2 test of independence. Treatment success will be
determined by the GROC at each period with success de-
fined as a GROC of +5, “a great deal better”, or greater.
Economic evaluation
An economic evaluation will be conducted alongside this
randomized clinical trial in accordance with established
methods [58,59]. Costs and consequences of ePT and
uPOD from the viewpoint of a healthcare payer and so-
ciety will be estimated using billing records and a
participant-reported questionnaire at all follow-up time
points. Incremental cost effectiveness will be reported
using quality-adjusted life-years derived from the
EQ-5D™ and index scores from the United States [37]. A
separate protocol paper will describe the methods of the
economic evaluation in greater detail and in accordance
with recommendations from publication guidelines for
economic evaluations [60].
Discussion
This paper describes the methods of a randomized clin-
ical trial comparing ePT and uPOD for PHP. The pro-
posed work builds on emerging evidence indicating the
benefit of early physical therapy intervention [27-29],
which has not been established in a population of indi-
viduals with PHP. In addition, previous investigations
have analyzed the outcome associated with individual or1–2 combined interventions for PHP. This is the first
pragmatic study, as far as we are aware, that investigates
the role and cost-effectiveness of impairment-based
physical therapy intervention early in the multi-disciplinary
management of PHP. The implications of this work ad-
dress national concerns about rising healthcare costs in the
American healthcare system, will help inform clinical
guidelines, and benefit multiple healthcare providers in-
volved in PHP management. This trial is registered at
clinicaltrials.gov, identifier NCT01865734 to increase
transparency of trial. The results of this investigation
will be submitted for publication in peer-reviewed
journals and presented at local and national meetings
regardless of the outcome. The Orthopaedic Section,
APTA, Inc. will be credited for monetary support pro-
vided for this work in all publications and presentations.
Limitations
This study will be the first to compare uPOD and ePT
and this investigation will be conducted at one location,
the Des Moines University Clinic. As a result, the find-
ings may have limited generalizability to other settings.
In addition, treatments provided by both groups will be
done at the discretion of the provider. There will be six
Podiatrists and four Physical Therapists providing treat-
ment, which may result in variation of treatment within
each group. Efforts will be made to reduce variation by
providing a guide based upon current best evidence for
the physical therapy intervention (Tables 2 and 3), but
the intent of this trial is to capture the value and differ-
ences of pragmatic clinical approaches used to manage
PHP. This may result in difficulty describing specific
details about treatment beyond reporting of Current
Procedural Terminology codes used when treatment is
billed, but general aspects of treatment will be de-
scribed in as much detail as possible.
The inclusion and exclusion criteria used in this inves-
tigation will help to reduce the likelihood of confound-
ing factors but will also limit the generalizability of
results. The results of this investigation may not apply to
individuals with a BMI greater than 30 kg/m2, PHP
symptoms for longer than 1 year in duration, older than
60 years of age, or comorbid conditions that were ex-
cluded in this trial (e.g., osteoporosis, rheumatic inflam-
matory diseases, severe peripheral artery disease).
All participants in this study will be seen by a podia-
trist first and therefore the results of this investigation
will apply to clinical scenarios when an individual pre-
sents first to podiatry with PHP. Preliminary unpub-
lished investigation at the Des Moines University Clinic
indicates that a significant majority of patients present
first to podiatry than to any other specialty for PHP, but
no other investigations were found to describe the preva-
lence of patient presentation to the primary providers for
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patterns of patient entry to the healthcare system for PHP.
The results of this investigation may be limited in clinical
scenarios where the patient may present to another pro-
vider first or does not receive an evaluation and treatment
from a podiatrist initially.
Additional file
Additional file 1: Participant expectation and preference
questionnaire.
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